Although many investigators have centred in the activation and targeting of tumour-specific CD8+ CTL and CD4+ T cells are required for the priming and maintenance of CD8+ T cells (Janssen et al, 2003; Smith et al, 2004; Sun et al, 2004). This evidence concerns the gene CD4 and neoplasm.